A series of N-peptidyl-O-acyl hydroxylamines was synthesized and tested as inactivators of cysteine proteinases. Depending on the structure of the peptidyl residue of the inhibitors, rapid and complete irreversible inactivation of the lysosomal cathepsins, B, L and S, may be achieved. The most effective inhibitors display second-order rate constants of the inactivation in the range l05-106 M-1 s-1. By contrast, the activity of the aminoendopeptidase cathepsin H is only negligibly affected by the N-terminal-protected peptidyl inhibitors.
INTRODUCTION
The lysosomal cathepsins B, H, L and S are well characterized cysteine proteinases and play an important role in intracellular protein breakdown (Kirschke & Barrett, 1987) . Furthermore, it has been shown previously that cathepsins B and L are involved in the degradation of extracellular-matrix proteins such as collagen and elastin (Burleigh et al., 1974; Kirschke et al., 1982; Mason et al., 1986) and may take part in osteoporosis (Delaisse et al., 1984) , pulmonary emphysema (Mason, 1988) and tumour invasion (Denhardt et al., 1987) .
The design of specific irreversible inhibitors could therefore be a useful contribution in studying the role of these proteinases in disease.
Favoured inhibitors should be specific for one type of proteinase and should not induce non-specific side reactions. This goal may be reached by using enzymeactivated inhibitors that generate their inhibiting power only during the catalytic action of the target enzyme.
Searching for new inactivators of dipeptidyl peptidase IV (DP IV, EC 3.4.15.5) we developed N-peptidyl-Oaroyl hydroxylamines as potential mechanism-based inhibitors of serine and cysteine proteinases (Fischer et al., 1982 (Fischer et al., , 1983 Demuth et al., 1988 Demuth et al., , 1989a . Diacyl hydroxylamine derivatives (R1 -CO -NH -0 -CO -R2) permit variations of the N-acyl and O-acyl residues and thus a selective control of their affinity and reactivity towards the enzymes.
Using DP IV as model enzyme we studied the inactivation reactions, enzyme-catalysed turnover and spontaneous degradation of a series of substrate-analogous N-Xaa-Pro-O-benzoyl hydroxylamines (Demuth et al., 1988) . The inhibitors have been successfully used in biological investigations to evaluate the participation of DP IV in human T-lymphocyte activation (Sch6n et al., 1984 (Sch6n et al., , 1987 (Sch6n et al., , 1989 . Smith et al. (1988) have demonstrated the potential of this new inhibitor class to inactivate the cysteine proteinase cathepsin B.
In the present paper we report the rapid and selective inactivation, by several N-peptidyl-O-acyl hydroxylamines, of several lysosomal cysteine proteinases exhibiting different substrate specificities.
EXPERIMENTAL Enzymes
Cathepsin B (EC 3.4.22.1), cathepsin L (EC 3.4.22.15) and cathepsin H (EC 3.4.22.16) were prepared from the lysosomal fraction of rat liver as described by Kirschke et al. (1977) and Barrett & Kirschke (1981) . Bovine spleen cathepsin S (EC 3.4.22.-) was isolated as described by Kirschke et al. (1986) . All cathepsins used were in an electrophoretically homogeneous form. Substrates and inhibitors Z-Phe-Arg-NHMec, Arg-NHMec HCI and Z-ValVal-Arg-NHMec were synthesized as in Bromme et al. (1989a,b) .
N-Peptidyl-O-acyl hydroxylamines have been used from previous experiments or synthesized as described (Fischer et al., 1983; Demuth et al., 1988 Demuth et al., , 1989a 
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where EI-, E-I, k1 and k-1 represent the enzymeinhibitor complex, the inactivated enzyme and the rate constants of non-covalent reaction steps respectively.
kinact is the rate constant of the formation of covalent modified enzyme. This rate constant may be determined as described by Kitz & Wilson (1962) Table 3 ) and cathepsin S with Boc-Ala-Phe-Leu-NHO-Nbz (compound 8) for I h in molar enzyme/inhibitor ratios of 1:1000 and 1:100 respectively, the enzymes were completely inactivated. No regeneration of activity within 1-5 h could be observed after removal of excess inhibitor by exhaustive ultrafiltration (up to an enzyme/free inhibitor ratio of < 1:0.05) or by chromatography on Sephadex G-10.
Typical progress curves for the cathepsin S-catalysed hydrolysis of Z-Val-Val-Arg-NHMec in the presence of the inhibitor Boc-Gly-Phe-Phe-NHO-Nbz are shown in Fig. 1 and N-Z-Phe-Gly-O-mesitoyl hydroxylamine. In contrast, DP IV hydrolyses substrate-analogous diacyl hydroxylamines to a remarkable extent, exhibiting partition ratios between 8000 to 200000 (Demuth et al., 1988) . The compounds 1, 2 and 7 (Table 4) are not suited to an effective inactivation of the lysosomal cathepsins. This is due to the non-specific peptide sequence of the inhibitors. Proline especially, in the P1 or P2 position prevents or disturbs interactions between the inhibitor and the target enzyme (Mason et al., 1984; Bromme et al., 1987) . The same holds true for small amino acid residues in the P2 position. A substitution of the P2 residue by the specific subsite residue phenylalanine gives L and B (compounds 3-6, 8 and 9) . The preference for aromatic hydrophobic residues in the S2 subsite by cathepsins B and L had already been shown with various other inhibitors and substrates (Barrett & Kirschke, 1981; Kirschke & Shaw, 1981; Crawford et al., 1988; Kirschke et al., 1988) .
Introduction of an additional hydrophobic residue such as phenylalanine or leucine into the P1 position gives the most potent inhibitors of cathepsin L (compounds 6, 8 and 9). This is in agreement with the wellknown high affinity ofcathepsin L for bulky hydrophobic side chains in its subsites, Si and S2 (Kirschke et al., 1988) . Z-Phe-Phe-NHO-Ma (compound 6 in Table 3 ; The best inhibitors of cathepsin S are the tripeptide derivatives Boc-Ala-Phe-Leu-NHO-Nbz (Fig. 3) and Boc-Gly-Phe-Phe-NHO-Nbz, exhibiting one order of magnitude higher second-order inactivation rate constants compared with the most effective dipeptide derivatives. However, they do not allow one to differentiate between cathepsins S and L.
Compared with cathepsins L and S, cathepsin B is inhibited relatively slowly by the peptide inhibitors tested. Similar ratios of second-order inactivation rate constants have been found when cathepsins B and L were inactivated by peptidyl diazomethanes (Crawford et al., 1988 Smith et al. (1988) were able to demonstrate a clear correlation between the efficiency of N,O-diacyl hydroxylamine derivatives and the lipophilicity of the 0-acyl group. Thus the effect of systematic variation in the 0-acyl residue requires investigation.
So far the mechanism of proteinase inactivation by diacyl hydroxylamines has not yet been established. However, in a preliminary report , we published studies on the spontaneous degradation of N-peptidyl-0-(4-nitrobenzoyl) hydroxylamines in aqueous solution indicating that heterolytic -N-0-bond fission of the hydroxylamine linkage is a rate-determining step of this reaction, as in a Lossen reaction (Bauer & Exner, 1974) .
It is worth mentioning here that the more electronwithdrawing the 0-acyl residues in N-peptidyl-0-acyl hydroxylamines are, the faster the enzyme inactivation occurs (Demuth et al., 1988) . Therefore this residue may also be used to preselect stability and efficacy of proteinase inhibitors in aqueous solution from a pharmacokinetic point of view. Comparing stability data given in Demuth et al. (1988 Demuth et al. ( , 1989a and in Table 2 , it becomes obvious that the nature of the amino acid side chain in the N-acyl residue (P1 amino acid) also influences the decomposition rate of the compounds in solution. The empirical range of decomposition-promoting ability is: Gly < Pro, Ala < Leu, Val < Phe.
If one compares the second-order rate constants of the inactivation of target enzymes from the different proteinase classes (Table 4 ) the efficacy of the new inhibitor type in reactions with cysteine proteinases becomes obvious.
Similar differences in specificity have been described for the inactivation of serine and cysteine proteinases by peptidyl diazomethanes (Zumbrunn et al., 1988) . The Npeptidyl-0-acyl hydroxylamine inhibitors tested so far may therefore be considered to be specific for cysteine proteinases.
